Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the United States, the world's most lucrative healthcare market -- a multi-trillion-dollar behemoth where investment opportunities abound.
Sifting through the industry revealed three blue chip stocks with stellar records of execution, future growth opportunities, and an enticing dividend. They offer both passive income and reinvestment potential that could boost overall returns.
Here is why Johnson Johnson (NYSE: JNJ), Abbott Labs (NYSE: ABT), and (NYSE: PFE) should all be on your radar as a long-term investor. You can own a share of each for less than $1,000 all-in.
Source Fool.com
Pfizer Inc. Stock
The stock is one of the favorites of our community with 28 Buy predictions and 4 Sell predictions.
As a result the target price of 40 € shows a very positive potential of 51.54% compared to the current price of 26.4 € for Pfizer Inc..